Value & Evidence Strategy Lead in Zurich

  • Salary: Up to 100 CHF per hour
  • REF Number: 00043503
  • Consultant: Crystal Spilsbury
  • Contact: 0417276793
  • Date Published: 28.09.2018
  • Closed Date: 22.10.2018
  • Sector:
  • Location: Zurich, Switzerland,
  • Discipline:

Value & Evidence Strategy Lead - Zurich, Switzerland

Crystal Spilsbury is recruiting for a Value & Evidence Strategy Lead to join a leading innovative pharmaceutical company at their site based in Zurich on a contract basis for 6 months.

The main purpose of the role will be to:

  • Be the primary advisor to the LOCs, via Evidence and Value Generation Hub (EVGH), on planning, communicating and generating evidence that will optimise patient access for Takeda medicines.
  • Prioritise evidence needs with EUCAN and EM to assist in generating a common position for communication to global teams.
  • Generate RWE / Payer Solutions by improvement of RWE standards, RWE infrastructure development, and use of new regulatory pathways.
  • Develop patient reported outcomes in collaboration with various teams.
  • Interfacing with the internal partners from Global Market Access, Global clinical development team and the members of the EVGH, as well as external HE experts.
  • Developing Health-Economics Models, systematic literature reviews and indirect treatment comparisons in collaboration with various teams.
  • Collaborate with the EVGH, Centres of Excellence (CoEs), and Global Market Access Team members to support needs for HE modelling and assessments that can support brand value evaluation.
  • Support needs for HE modelling and assessments that can support brand value evaluation.
  • Serving as a capability building / “training centre” for HE & HTA topics.

In order to be considered for this role, you will be required to have the following qualifications, skills and experience:

  • Master or PhD level with a focus in analytics (ie, economics, pharmacy, biostatistics, econometrics, statistics or mathematics).
  • Previous experience within Pharmaceutical would be advantageous, although consultancy experience is considered.
  • Previous experiences in HE&OR modelling (CEA, CUA, BIM, HTA submissions, meta-analysis, MTC, ITC, Kaplan-Meyer analysis, etc…including program development and users guides) would be beneficial.
  • Experience in developing HEOR strategy to support value proposition development for innovative medical products.
  • Strong experience in performing statistical/mathematical modelling using techniques such as decision tree analysis, Markov Modelling, Discrete event simulations.
  • Strong understanding of global payer environment, including coverage and reimbursement, pricing and contracting, formulary management and health technology assessment.- Good understanding of clinical development and the needs of HTAs and payers from clinical trials and development programs.

This is an excellent opportunity to join a global, expanding pharmaceutical company.

For more information or to apply for this position, please contact Crystal on +41 (0) 417276793 or email jblackham@ckqls.ch. Please quote reference QLS43503 in all correspondence.

We'll store this in session so if you're applying for multiple jobs today so you can use this as a base.